Newer epilepsy drugs taken while pregnant not linked to lower IQs in children
Valproate, one of the most commonly prescribed antiepileptic medications, has been associated in the past with birth defects and developmental problems. However, two newer drugs -- levetiracetam and topirimate -- have had little or no investigations into their developmental impact until this latest research, published published in the August 31, 2016, issue of Neurology®, the medical journal of the American Academy of Neurology. Lead researcher and author of the paper Dr Rebecca Bromley, of The University of Manchester's School of Biological Sciences, said expectant mothers had to know the possible impacts their drug regimes may have on unborn children. "Over the past few years, doctors have been moving away from prescribing valproate to pregnant women, shifting them to the two newer antiepileptic drugs. But, until now, there hasn't been any definitive research to understand what implications for IQ and development these two drugs may have. "Working with fund...